Clinical Trial

T6A Biomarker for Detection of Bacterial Infection in Newborn Infants

Name: T6A Biomarker for Detection of Bacterial Infection in Newborn Infants — clinical trial record (NCT07670624)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: T6ASepsis

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study aims to assess the efficacy of a new biomarker, N6-threonylcarbamoyladenosine (t6A), for the early diagnosis of Early-Onset Sepsis (EOS) in newborns.

Trial Details

NCT Number	NCT07670624
Lead Sponsor	Salzburger Landeskliniken Collaborators: Wroclaw Medical University, Ludwig Boltzmann Gesellschaft
Conditions	Sepsis, Newborn Sepsis, Biomarker Discovery
Enrollment	210 participants
Start Date	2026-07-01
Primary Completion	2029-01-31 (estimated)
Study Completion	2029-01-31 (estimated)
Updated on ClinicalTrials.gov	2026-07-30